By Alaina Lancaster | December 7, 2022
"Holmes is part of this case, but she's not part of this sentence," said U.S. District Judge Edward Davila.
By Scott Graham | December 5, 2022
The pharmaceutical companies fired back hard at Moderna's suit Monday with the help of Williams & Connolly; Paul Hastings; McCarter & English and Saul Ewing. They argue that Moderna relinquished its rights by publicly pledging not to enforce its patents during the pandemic.
By Alaina Lancaster | November 18, 2022
"I feel like my family home was desecrated by Elizabeth and the lawyers," said Alex Shultz, father of whistleblower Tyler Shultz and son of George Shultz, former Theranos board member and U.S. secretary of state, in an impromptu statement to the court.
By Scott Graham | November 8, 2022
Bristol-Myers Squibb had won a $1.2 billion judgment for infringement of its patent on a cancer treatment. But the justices left in place a Federal Circuit decision that invalidated the patent for failing to meet the Patent Act's written description requirement.
By Scott Graham | November 4, 2022
It's a big day for MoloLamken partner Jeffrey Lamken, who is counsel of record to petitioners Amgen and Abitron.
By Scott Graham | October 31, 2022
The professor was a popular and active presence in intellectual property circles. He was found dead in his DC apartment on Sunday for reasons that are not yet clear.
By Scott Graham | September 27, 2022
The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.
By Dan Packel | August 26, 2022
Bill Lee, the lead lawyer in Moderna's complaint, had previously represented Pfizer in a $2.15 billion settlement with generic drug makers.
By Scott Graham | August 3, 2022
A former PTO director and a former Federal Circuit judge hailed the legislation as providing clarity and predictability in a contentions area of law. An attorney for a tech industry trade group warned that, as written, the bill would roll back advances against abusive patent litigation.
By Scott Graham | July 18, 2022
Latham and Goodwin Procter persuaded the Federal Circuit that CareDx patents for detecting organ transplant rejection are invalid because they apply a natural law using conventional techniques. Weil Gotshal argues that the patented techniques are anything but conventional, and that the decision will "suffocate innovation in the life-saving arts."
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS